|
9th Influenza Conference 2023
Unveiling the Roles of Metabolism and Genetics
Cracking the code of severe disease
|
9th Influenza Conference 2023
Investigating the Antigenic Evolution of Influenza B Viruses and RSV
How respiratory viruses can change
|
9th Influenza Conference 2023
Best practices in vaccination programmes for risk groups and healthcare workers
SPI03 session from #ESWI2023
|
9th Influenza Conference 2023
Why influenza and RSV disease are a priority for policy makers
SPI01 session from #ESWI2023
|
9th Influenza Conference 2023
The bidirectional relationship between influenza and diabetes mellitus
The IDC partner symposium addressed questions like why influenza and diabetes are important to consider jointly; whether there is a bidirectional relationship; role of influenza vaccination on diabetes progression; how to improve vaccination uptake...
International scientific community gathers in Valencia for the 9th ESWI Conference on Influenza, COVID-19, and RSV
Since it was established 30 years ago, the European Scientific Working Group on Influenza and other Acute Respiratory Viruses (ESWI) is hosting the 9TH ESWI Influenza Conference
SARS-CoV-2-related mortality decrease in nursing home residents given multiple COVID-19 boosters
Two doses of COVID-19 mRNA vaccines in the primary series and a booster dose induce a strong antibody response, however, this response can be weak in people older than 80 years.
Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6
Although WHO has declared an end to the emergency phase of the COVID-19 pandemic, SARS-CoV-2 has continued to spread and evolve, giving rise to new variants.
Guidance for Developing a Sustainable Multistakeholder Immunization Coalition
Insights from immunization coalition experts and analysis of successful immunization coalitions